» Articles » PMID: 33918425

Experimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose

Abstract

The results of structural studies on a series of halogen-substituted derivatives of 2-deoxy-D-glucose (2-DG) are reported. 2-DG is an inhibitor of glycolysis, a metabolic pathway crucial for cancer cell proliferation and viral replication in host cells, and interferes with D-glucose and D-mannose metabolism. Thus, 2-DG and its derivatives are considered as potential anticancer and antiviral drugs. X-ray crystallography shows that a halogen atom present at the C2 position in the pyranose ring does not significantly affect its conformation. However, it has a noticeable effect on the crystal structure. Fluorine derivatives exist as a dense 3D framework isostructural with the parent compound, while Cl- and I-derivatives form layered structures. Analysis of the Hirshfeld surface shows formation of hydrogen bonds involving the halogen, yet no indication for the existence of halogen bonds. Density functional theory (DFT) periodic calculations of cohesive and interaction energies (at the B3LYP level of theory) have supported these findings. NMR studies in the solution show that most of the compounds do not display significant differences in their anomeric equilibria, and that pyranose ring puckering is similar to the crystalline state. For 2-deoxy-2-fluoro-D-glucose (2-FG), electrostatic interaction energies between the ligand and protein for several existing structures of pyranose 2-oxidase were also computed. These interactions mostly involve acidic residues of the protein; single amino-acid substitutions have only a minor impact on binding. These studies provide a better understanding of the structural chemistry of halogen-substituted carbohydrates as well as their intermolecular interactions with proteins determining their distinct biological activity.

Citing Articles

Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-d-Glucose in a Glioblastoma Model.

Soltyka-Krajewska M, Ziemniak M, Zawadzka-Kazimierczuk A, Skrzypczyk P, Siwiak-Niedbalska E, Jaskiewicz A Biomedicines. 2024; 12(10).

PMID: 39457553 PMC: 11504489. DOI: 10.3390/biomedicines12102240.


Conformations and Physicochemical Properties of Biological Ligands in Various Environments.

Le Questel J Int J Mol Sci. 2023; 24(11).

PMID: 37298581 PMC: 10254052. DOI: 10.3390/ijms24119630.


The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.

Pajak B, Zielinski R, Manning J, Matejin S, Paessler S, Fokt I Molecules. 2022; 27(18).

PMID: 36144664 PMC: 9503362. DOI: 10.3390/molecules27185928.


X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution.

Ziemniak M, Pawledzio S, Zawadzka-Kazmierczuk A, Dominiak P, Trzybinski D, Kozminski W RSC Adv. 2022; 12(14):8345-8360.

PMID: 35424802 PMC: 8985090. DOI: 10.1039/d1ra08312k.

References
1.
Grimme S . Semiempirical GGA-type density functional constructed with a long-range dispersion correction. J Comput Chem. 2006; 27(15):1787-99. DOI: 10.1002/jcc.20495. View

2.
Grimme S . Accurate description of van der Waals complexes by density functional theory including empirical corrections. J Comput Chem. 2004; 25(12):1463-73. DOI: 10.1002/jcc.20078. View

3.
Pina Y, Decatur C, Murray T, Houston S, Lopez-Cavalcante M, Hernandez E . Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors. Invest Ophthalmol Vis Sci. 2012; 53(2):996-1002. PMC: 3317436. DOI: 10.1167/iovs.11-8265. View

4.
Meanwell N . Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. J Med Chem. 2018; 61(14):5822-5880. DOI: 10.1021/acs.jmedchem.7b01788. View

5.
Sheldrick G . Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem. 2015; 71(Pt 1):3-8. PMC: 4294323. DOI: 10.1107/S2053229614024218. View